[
    [
        {
            "time": "2018-03-15",
            "original_text": "Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "earnings growth",
                    "Wall Street"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-16",
            "original_text": "U.S. Stocks Set to Fall on Renewed China Concerns",
            "features": {
                "keywords": [
                    "U.S. Stocks",
                    "China Concerns",
                    "Fall"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "global trade"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "U.S. Stocks Set to Fall on Renewed China Concerns",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-17",
            "original_text": "Lilly's pancreatic cancer treatment fails late-stage study",
            "features": {
                "keywords": [
                    "Lilly",
                    "pancreatic cancer",
                    "fails",
                    "late-stage study"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly's pancreatic cancer treatment fails late-stage study",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-18",
            "original_text": "Eli Lilly says late-stage trial of pancreatic cancer treatment failed to meet its main goal of overall survival",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "pancreatic cancer",
                    "failed",
                    "main goal",
                    "overall survival"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly says late-stage trial of pancreatic cancer treatment failed to meet its main goal of overall survival",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-19",
            "original_text": "Lilly Announces Phase 3 Study in Patients with Metastatic Pancreatic Cancer Did Not Meet Primary Endpoint of Overall Survival",
            "features": {
                "keywords": [
                    "Lilly",
                    "Phase 3 Study",
                    "Metastatic Pancreatic Cancer",
                    "Did Not Meet",
                    "Primary Endpoint",
                    "Overall Survival"
                ],
                "sentiment_score": -0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly Announces Phase 3 Study in Patients with Metastatic Pancreatic Cancer Did Not Meet Primary Endpoint of Overall Survival",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-20",
            "original_text": "How to Cut Your 2019 Tax Bill Before It’s Too Late",
            "features": {
                "keywords": [
                    "Tax Bill",
                    "Cut",
                    "2019"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "How to Cut Your 2019 Tax Bill Before It’s Too Late",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-03-21",
            "original_text": "Eli Lilly Phase 3 Pancreatic Cancer Study Fails to Meet Primary Endpoint",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Phase 3",
                    "Pancreatic Cancer",
                    "Fails",
                    "Primary Endpoint"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly Phase 3 Pancreatic Cancer Study Fails to Meet Primary Endpoint",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]